APA

United States, . (2017). Why are some generic drugs skyrocketing in price?: hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014. Washington: U.S. Government Publishing Office.

Chicago

United States, . 2017. Why are some generic drugs skyrocketing in price?: hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014. Washington: U.S. Government Publishing Office.

Harvard

United States, . (2017). Why are some generic drugs skyrocketing in price?: hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014. Washington: U.S. Government Publishing Office.

MLA

United States, . Why are some generic drugs skyrocketing in price?: hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014. Washington: U.S. Government Publishing Office. 2017.